Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
$11.11
-0.6%
$8.72
$4.93
$14.44
$948.48M0.721.19 million shs882,691 shs
The Boeing Company stock logo
BA
Boeing
$226.68
+0.3%
$206.14
$128.88
$230.20
$171.04B1.419.55 million shs6.53 million shs
Carnival Corporation stock logo
CCL
Carnival
$28.67
-1.5%
$24.36
$13.78
$30.46
$33.46B2.6125.25 million shs14.57 million shs
Etsy, Inc. stock logo
ETSY
Etsy
$57.87
-0.5%
$52.91
$40.05
$66.81
$6.03B1.744.34 million shs3.41 million shs
Exelixis, Inc. stock logo
EXEL
Exelixis
$44.86
-0.7%
$42.42
$22.20
$49.62
$12.23B0.282.53 million shs2.06 million shs
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$11.53
-5.2%
$9.06
$5.90
$28.18
$1.19B2.213.04 million shs3.73 million shs
QAD Inc. stock logo
QADA
QAD
$87.63
$87.57
$44.10
$89.01
$1.84B1.27122,788 shsN/A
Ventas, Inc. stock logo
VTR
Ventas
$64.76
+2.3%
$63.87
$52.45
$71.36
$29.23B0.872.91 million shs4.36 million shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
0.00%+3.64%+35.16%+25.40%+140.48%
The Boeing Company stock logo
BA
Boeing
0.00%+5.07%+11.25%+44.43%+23.38%
Carnival Corporation stock logo
CCL
Carnival
0.00%-4.31%+21.74%+62.02%+61.61%
Etsy, Inc. stock logo
ETSY
Etsy
0.00%+6.38%-2.40%+32.73%+0.96%
Exelixis, Inc. stock logo
EXEL
Exelixis
0.00%-2.29%+7.37%+27.05%+103.45%
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
0.00%+7.61%+38.08%+55.60%-50.19%
QAD Inc. stock logo
QADA
QAD
0.00%0.00%0.00%0.00%0.00%
Ventas, Inc. stock logo
VTR
Ventas
0.00%+2.91%+1.65%-1.94%+24.28%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
3.7744 of 5 stars
3.71.00.04.71.60.80.6
The Boeing Company stock logo
BA
Boeing
3.224 of 5 stars
2.45.00.00.01.82.50.6
Carnival Corporation stock logo
CCL
Carnival
4.6089 of 5 stars
2.32.00.03.13.11.74.4
Etsy, Inc. stock logo
ETSY
Etsy
3.5798 of 5 stars
2.02.00.02.42.62.51.9
Exelixis, Inc. stock logo
EXEL
Exelixis
4.7869 of 5 stars
2.22.00.04.33.22.54.4
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
4.3493 of 5 stars
4.31.00.04.71.42.50.6
QAD Inc. stock logo
QADA
QAD
N/AN/AN/AN/AN/AN/AN/AN/A
Ventas, Inc. stock logo
VTR
Ventas
4.5654 of 5 stars
2.54.01.73.63.62.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
3.33
Buy$44.00296.04% Upside
The Boeing Company stock logo
BA
Boeing
2.72
Moderate Buy$216.32-4.57% Downside
Carnival Corporation stock logo
CCL
Carnival
2.65
Moderate Buy$28.65-0.08% Downside
Etsy, Inc. stock logo
ETSY
Etsy
2.00
Hold$49.91-13.75% Downside
Exelixis, Inc. stock logo
EXEL
Exelixis
2.48
Hold$44.72-0.31% Downside
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
2.65
Moderate Buy$33.37189.41% Upside
QAD Inc. stock logo
QADA
QAD
0.00
N/AN/AN/A
Ventas, Inc. stock logo
VTR
Ventas
3.00
Buy$72.9012.57% Upside

Current Analyst Ratings Breakdown

Latest BA, VTR, ETSY, NTLA, CCL, EXEL, AVXL, and QADA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/10/2025
Etsy, Inc. stock logo
ETSY
Etsy
Citizens Jmp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
7/10/2025
Exelixis, Inc. stock logo
EXEL
Exelixis
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$29.00 ➝ $40.00
7/9/2025
The Boeing Company stock logo
BA
Boeing
Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetPositive ➝ Positive$240.00 ➝ $252.00
7/8/2025
Exelixis, Inc. stock logo
EXEL
Exelixis
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Sector Perform$45.00 ➝ $50.00
6/30/2025
Etsy, Inc. stock logo
ETSY
Etsy
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetUnderweight ➝ Underweight$40.00 ➝ $41.00
6/30/2025
Exelixis, Inc. stock logo
EXEL
Exelixis
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$47.00 ➝ $53.00
6/27/2025
The Boeing Company stock logo
BA
Boeing
Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy$180.00 ➝ $275.00
6/27/2025
The Boeing Company stock logo
BA
Boeing
Rothschild & Co Redburn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$275.00
6/26/2025
Carnival Corporation stock logo
CCL
Carnival
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$21.00 ➝ $24.00
6/25/2025
Carnival Corporation stock logo
CCL
Carnival
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$28.00 ➝ $30.00
6/25/2025
Carnival Corporation stock logo
CCL
Carnival
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$33.00 ➝ $35.00
(Data available from 7/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
N/AN/AN/AN/A$1.42 per shareN/A
The Boeing Company stock logo
BA
Boeing
$66.52B2.57N/AN/A($5.23) per share-43.34
Carnival Corporation stock logo
CCL
Carnival
$25.97B1.29$3.98 per share7.21$8.57 per share3.35
Etsy, Inc. stock logo
ETSY
Etsy
$2.81B2.15$3.66 per share15.83($6.75) per share-8.57
Exelixis, Inc. stock logo
EXEL
Exelixis
$2.30B5.32$1.93 per share23.29$7.86 per share5.71
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$45.57M26.21N/AN/A$8.56 per share1.35
QAD Inc. stock logo
QADA
QAD
$307.86M5.98$1.39 per share62.96$6.19 per share14.16
Ventas, Inc. stock logo
VTR
Ventas
$4.92B5.94$3.12 per share20.74$25.82 per share2.51
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
-$43M-$0.55N/AN/AN/AN/A-40.93%-36.38%8/5/2025 (Estimated)
The Boeing Company stock logo
BA
Boeing
-$11.82B-$17.92N/A84.27N/A-16.58%N/A-8.57%7/30/2025 (Estimated)
Carnival Corporation stock logo
CCL
Carnival
$1.92B$1.8515.5013.720.639.72%27.88%5.20%9/29/2025 (Estimated)
Etsy, Inc. stock logo
ETSY
Etsy
$303.28M$1.4041.3419.293.186.69%-39.60%12.30%7/30/2025 (Estimated)
Exelixis, Inc. stock logo
EXEL
Exelixis
$521.27M$2.2020.3917.590.9027.99%28.81%21.94%8/5/2025 (Estimated)
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
-$519.02M-$5.23N/AN/AN/A-1,154.10%-56.06%-44.25%8/14/2025 (Estimated)
QAD Inc. stock logo
QADA
QAD
$11.06M$0.33265.551,251.86N/A2.11%10.03%3.84%N/A
Ventas, Inc. stock logo
VTR
Ventas
$81.15M$0.33196.2417.552.332.80%1.36%0.56%7/30/2025 (Estimated)

Latest BA, VTR, ETSY, NTLA, CCL, EXEL, AVXL, and QADA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q3 2025
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
-$0.13N/AN/AN/AN/AN/A
8/5/2025Q2 2025
Exelixis, Inc. stock logo
EXEL
Exelixis
$0.63N/AN/AN/A$574.36 millionN/A
7/30/2025Q2 2025
The Boeing Company stock logo
BA
Boeing
-$0.92N/AN/AN/A$20.13 billionN/A
7/30/2025Q2 2025
Etsy, Inc. stock logo
ETSY
Etsy
$0.53N/AN/AN/A$645.16 millionN/A
6/24/2025Q2 2025
Carnival Corporation stock logo
CCL
Carnival
$0.24$0.35+$0.11$0.42$6.20 billion$6.33 billion
5/13/2025Q2 2025
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
-$0.16-$0.13+$0.03-$0.13N/AN/A
5/8/2025Q1 2025
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
-$1.26-$1.10+$0.16-$1.10$11.39 million$16.63 million
4/30/2025Q1 2025
Etsy, Inc. stock logo
ETSY
Etsy
$0.50$0.46-$0.04-$0.49$642.22 million$651.18 million
4/30/2025Q1 2025
Ventas, Inc. stock logo
VTR
Ventas
$0.82$0.84+$0.02$0.84$1.32 billion$1.36 billion
4/23/2025Q1 2025
The Boeing Company stock logo
BA
Boeing
-$1.39-$0.49+$0.90-$0.16$19.57 billion$19.50 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
N/AN/AN/AN/AN/A
The Boeing Company stock logo
BA
Boeing
N/AN/AN/AN/AN/A
Carnival Corporation stock logo
CCL
Carnival
$2.006.98%N/A108.11%N/A
Etsy, Inc. stock logo
ETSY
Etsy
N/AN/AN/AN/AN/A
Exelixis, Inc. stock logo
EXEL
Exelixis
N/AN/AN/AN/AN/A
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
N/AN/AN/AN/AN/A
QAD Inc. stock logo
QADA
QAD
$0.290.33%N/A87.88%N/A
Ventas, Inc. stock logo
VTR
Ventas
$1.922.96%N/A581.82%1 Years

Latest BA, VTR, ETSY, NTLA, CCL, EXEL, AVXL, and QADA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/13/2025
Ventas, Inc. stock logo
VTR
Ventas
quarterly$0.482.99%6/30/20256/30/20257/17/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
N/A
6.74
6.74
The Boeing Company stock logo
BA
Boeing
N/A
1.23
0.37
Carnival Corporation stock logo
CCL
Carnival
2.58
0.34
0.30
Etsy, Inc. stock logo
ETSY
Etsy
N/A
2.14
2.14
Exelixis, Inc. stock logo
EXEL
Exelixis
N/A
3.50
3.44
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
N/A
4.90
4.90
QAD Inc. stock logo
QADA
QAD
N/A
1.19
1.19
Ventas, Inc. stock logo
VTR
Ventas
1.10
0.32
0.32

Institutional Ownership

CompanyInstitutional Ownership
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
31.55%
The Boeing Company stock logo
BA
Boeing
64.82%
Carnival Corporation stock logo
CCL
Carnival
67.19%
Etsy, Inc. stock logo
ETSY
Etsy
99.53%
Exelixis, Inc. stock logo
EXEL
Exelixis
85.27%
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
88.77%
QAD Inc. stock logo
QADA
QAD
77.05%
Ventas, Inc. stock logo
VTR
Ventas
94.18%

Insider Ownership

CompanyInsider Ownership
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
11.40%
The Boeing Company stock logo
BA
Boeing
0.09%
Carnival Corporation stock logo
CCL
Carnival
7.60%
Etsy, Inc. stock logo
ETSY
Etsy
2.80%
Exelixis, Inc. stock logo
EXEL
Exelixis
2.82%
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
3.10%
QAD Inc. stock logo
QADA
QAD
44.92%
Ventas, Inc. stock logo
VTR
Ventas
0.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
4085.37 million75.64 millionOptionable
The Boeing Company stock logo
BA
Boeing
172,000754.01 million753.33 millionOptionable
Carnival Corporation stock logo
CCL
Carnival
100,0001.17 billion1.08 billionOptionable
Etsy, Inc. stock logo
ETSY
Etsy
2,400104.28 million101.36 millionOptionable
Exelixis, Inc. stock logo
EXEL
Exelixis
1,147272.71 million265.02 millionOptionable
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
600103.58 million100.37 millionOptionable
QAD Inc. stock logo
QADA
QAD
1,93021.01 million11.57 millionOptionable
Ventas, Inc. stock logo
VTR
Ventas
450451.30 million447.69 millionOptionable

Recent News About These Companies

Ventas (VTR) Could Be a Great Choice

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Anavex Life Sciences stock logo

Anavex Life Sciences NASDAQ:AVXL

$11.11 -0.07 (-0.63%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$11.06 -0.04 (-0.41%)
As of 07/11/2025 06:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases. Its lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. The company's drug candidate also comprises ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.

Boeing stock logo

Boeing NYSE:BA

$226.68 +0.59 (+0.26%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$231.13 +4.45 (+1.96%)
As of 07/11/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Boeing Company, together with its subsidiaries, designs, develops, manufactures, sells, services, and supports commercial jetliners, military aircraft, satellites, missile defense, human space flight and launch systems, and services worldwide. The company operates through Commercial Airplanes; Defense, Space & Security; and Global Services segments. The Commercial Airplanes segment develops, produces, and markets commercial jet aircraft for passenger and cargo requirements, as well as provides fleet support services. The Defense, Space & Security segment engages in the research, development, production, and modification of manned and unmanned military aircraft and weapons systems; strategic defense and intelligence systems, which include strategic missile and defense systems, command, control, communications, computers, intelligence, surveillance and reconnaissance, cyber and information solutions, and intelligence systems; and satellite systems, such as government and commercial satellites, and space exploration. The Global Services segment offers products and services, including supply chain and logistics management, engineering, maintenance and modifications, upgrades and conversions, spare parts, pilot and maintenance training systems and services, technical and maintenance documents, and data analytics and digital services to commercial and defense customers. The Boeing Company was incorporated in 1916 and is based in Arlington, Virginia.

Carnival stock logo

Carnival NYSE:CCL

$28.67 -0.43 (-1.48%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$28.67 0.00 (0.00%)
As of 07/11/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America and Australia (NAA) Cruise, Europe and Asia (EA) Cruise Operations, Cruise Support, and Tour and Others. The North America and Australia (NAA) Cruise segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe and Asia (EA) Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Etsy stock logo

Etsy NASDAQ:ETSY

$57.87 -0.29 (-0.50%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$57.47 -0.40 (-0.69%)
As of 07/11/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Etsy, Inc., together with its subsidiaries, operates two-sided online marketplaces that connect buyers and sellers in the United States, the United Kingdom, Germany, Canada, Australia, and France. Its primary marketplace is Etsy.com that connects artisans and entrepreneurs with various consumers. The company also offers Reverb, a musical instrument marketplace; Depop, a fashion resale marketplace; and Elo7, a Brazil-based marketplace for handmade and unique items. In addition, it offers various seller services, including Etsy Payments, a payment processing service; Etsy Ads, an advertising platform; and Shipping Labels, which allows sellers in the United States, Canada, the United Kingdom, Australia, and India to purchase discounted shipping labels. Further, the company provides the Etsy Purchase Protection program that is designed to help buyers; the Etsy Share and Save program for sellers to save on Etsy fees for sales that drive to their Etsy shop from their own channels. Additionally, it offers educational resources comprising blog posts, video tutorials, Etsy Seller Handbook, Etsy.com online forums, and insights; Etsy Teams, a platform to build personal relationships with other Etsy sellers; and a Star Seller program. The company was formerly known as Indieco, Inc changed its name to Etsy, Inc. in June 2006. Etsy, Inc. was founded in 2005 and is headquartered in Brooklyn, New York.

Exelixis stock logo

Exelixis NASDAQ:EXEL

$44.86 -0.31 (-0.69%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$44.92 +0.05 (+0.12%)
As of 07/11/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat specific forms of advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan. It develops zanzalintinib, a novel, potent, next-generation oral tyrosine kinase inhibitor (TKI) that targets VEGF receptors, MET and the TAM kinases (TYRO3, AXL and MER); and XB002, a next-generation tissue factor (TF)-targeting ADC, administered via intravenous infusion and composed of a human monoclonal antibody (mAb) against TF that is conjugated to an auristatin-based microtubulin inhibitor (MTI) payload. It has research collaborations and license agreements with Ipsen Pharma SAS; Takeda Pharmaceutical Company Ltd.; F. Hoffmann-La Roche Ltd.; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, Inc.; NBE Therapeutics AG; Aurigene Discovery Technologies Limited; Iconic Therapeutics, Inc.; Invenra, Inc.; StemSynergy Therapeutics, Inc.; Genentech, Inc.; Bristol-Myers Squibb Company; and Daiichi Sankyo Company, Limited, as well as clinical development agreement with Sairopa B.V. for ADU-1805. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was incorporated in 1994 and is headquartered in Alameda, California.

Intellia Therapeutics stock logo

Intellia Therapeutics NASDAQ:NTLA

$11.53 -0.63 (-5.18%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$11.51 -0.02 (-0.21%)
As of 07/11/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Intellia Therapeutics, Inc., a genome editing company, focuses on the development of curative therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; NTLA-2002 for the treatment of hereditary angioedema; and NTLA-3001 for alpha-1 antitrypsin deficiency associated lung disease. It also focusses on programs comprising hemophilia A and hemophilia B; and research of proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune diseases. In addition, the company offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. It has license and collaboration agreement with Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies, and co-develop and co-commercialize allogeneic universal CAR-T cell products for an immuno-oncology indication; SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of a variety of B cell-mediated autoimmune diseases; and ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

QAD stock logo

QAD NASDAQ:QADA

QAD, Inc. provides enterprise software solutions for global manufacturing companies primarily in the automotive, consumer products, food and beverage, technology, industrial products, and life sciences industries. Its applications provide critical functionality for managing manufacturing resources and operations within and beyond the enterprise, enabling global manufacturers to collaborate with their customers, suppliers and partners. The company was founded by Pamela Meyer Lopker in 1979 and is headquartered in Santa Barbara, CA.

Ventas stock logo

Ventas NYSE:VTR

$64.76 +1.48 (+2.34%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$64.00 -0.76 (-1.17%)
As of 07/11/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ventas Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust focused on delivering strong, sustainable shareholder returns by enabling exceptional environments that benefit a large and growing aging population. The Company's growth is fueled by its senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas leverages its unmatched operational expertise, data-driven insights from its Ventas Operational InsightsTM platform, extensive relationships and strong financial position to achieve its goal of delivering outsized performance across approximately 1,400 properties. The Ventas portfolio is composed of senior housing communities, outpatient medical buildings, research centers and healthcare facilities in North America and the United Kingdom. The Company benefits from a seasoned team of talented professionals who share a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.